Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1989
Chemoattractant-induced cytoplasmic pH changes and cytoskeletal reorganization in human neutrophils. Relationship to the stimulated calcium transients and oxidative burstP H Naccache, S Therrien, A C Caon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2003
A role for macrophage inflammatory protein-3 alpha/CC chemokine ligand 20 in immune priming during T cell-mediated inflammation of the central nervous systemRachel E Kohler, Adriana C Caon, David O Willenborg, et al.
European Journal of Neurology|May 8, 2008
Oral prednisone taper following intravenous steroids fails to improve disability or recovery from relapses in multiple sclerosisJ S Perumal, C Caon, S Hreha, et al.
Neurology|January 29, 2003
Intercaudate nucleus ratio as a linear measure of brain atrophy in multiple sclerosisC Caon, M Zvartau-Hind, W Ching, et al.
European Journal of Neurology|August 30, 2008
Treatment of corticosteroid refractory optic neuritis in multiple sclerosis patients with intravenous immunoglobulinA Tselis, J Perumal, C Caon, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 1, 1993
Inhibition of tyrosine phosphorylation by wortmannin in human neutrophils. Dissociation from its inhibitory effects on phospholipase DP H Naccache, A C Caon, C Gilbert, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 25, 2008
Failure to develop multiple sclerosis in patients with neurologic symptoms without objective evidenceA Boster, C Caon, J Perumal, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1994
Tyrosine phosphorylation in activated human neutrophils. Comparison of the effects of different classes of agonists and identification of the signaling pathways involvedE Rollet, A C Caon, C J Roberge, et al.
Blood|November 15, 1990
Selective inhibition of human neutrophil functional responsiveness by erbstatin, an inhibitor of tyrosine protein kinaseP H Naccache, C Gilbert, A C Caon, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 28, 2001
Effect of monthly intravenous cyclophosphamide in rapidly deteriorating multiple sclerosis patients resistant to conventional therapyO A Khan, M Zvartau-Hind, C Caon, et al.
Pageof 3